fingerlakes17h
FDA approves first new non-opioid painkiller in 20 years
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
Scientific Research Publishing10h
Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma in a 22-Year-Old Male ()
Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
Muscle pain: Cold plunge or hot bath, what works best?
There is also contrast therapy that is vividly used in physiotherapy, especially sports physiotherapy, where a cold bath is ...
cidrap.umn20h
After COVID-19, kids more likely to have GI symptoms for up to 2 years
Though long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), is more common in adults than in kids, 1.3% of US children ...
Hosted on MSN21h
Newly FDA-approved non-opioid painkiller is first of its kind in over 20 years
For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
verywellhealth23h
What’s the Difference Between Ubrelvy and Nurtec?
Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.